2. Gene
  3. Src - Rous sarcoma oncogene Gene

Src - Rous sarcoma oncogene Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：劳斯肉瘤致癌基因

种属: Mus musculus

同用名: pp60c-src

基因 ID: 20779 | 基因类型: protein coding

关于 Src

Chromosome 2: 157,260,364-157,313,782 forward strand.GRCm39:CM000995.3

This gene has 8 transcripts (splice variants), 261 orthologues, 32 paralogues and is associated with 54 phenotypes. Ubiquitous expression in duodenum adult (RPKM 49.), colon adult (RPKM 48.4) and 23 other tissues.

功能概要

该基因编码的蛋白可启动多种功能，包括连接蛋白结合活性； ephrin 受体结合活性；和支架蛋白结合活性。参与多个过程，包括白细胞介素6介导的信号通路；信号转导的正调控；和蛋白质不稳定。作用于多个过程的上游或内部，包括动物器官发育；细胞对生长因子刺激的反应；和信号转导的调节。位于几种细胞成分中，包括肌动蛋白细胞骨架；粘着斑；和荷叶边膜。以多种结构表达，包括中枢神经系统；早孕;泌尿生殖系统；直觉;和视网膜。用于研究 Williams-Beuren 综合症。该基因与结直肠癌相关的人类直系同源物（多个）；导管原位癌；前列腺癌;血小板减少症;和 2 型糖尿病。与人类 Src 同源（SRC 原癌基因，非受体酪氨酸激酶）。 [由基因组资源联盟提供，2022 年 4 月]

Enables several functions, including connexin binding activity; Ephrin Receptor binding activity; and scaffold protein binding activity. Involved in several processes, including interleukin-6-mediated signaling pathway; positive regulation of signal transduction; and protein destabilization. Acts upstream of or within several processes, including animal organ development; cellular response to growth factor stimulus; and regulation of signal transduction. Located in several cellular components, including actin cytoskeleton; focal adhesion; and ruffle membrane. Is expressed in several structures, including central nervous system; early conceptus; genitourinary system; gut; and retina. Used to study Williams-Beuren syndrome. Human ortholog(s) of this gene implicated in colorectal Cancer (multiple); ductal carcinoma in situ; prostate cancer; thrombocytopenia; and type 2 diabetes mellitus. Orthologous to human Src (Src proto-oncogene, non-receptor tyrosine kinase). [provided by Alliance of Genome Resources, Apr 2022]

Src 基因产物(13)

mRNA Protein Name
NM_001412690.1 NP_001399619.1 proto-oncogene tyrosine-protein kinase Src isoform 2
NM_001412691.1 NP_001399620.1 proto-oncogene tyrosine-protein kinase Src isoform 2
NM_001025395.3 NP_001020566.1 proto-oncogene tyrosine-protein kinase Src isoform 2
NM_001412689.1 NP_001399618.1 proto-oncogene tyrosine-protein kinase Src isoform 2
NM_001412693.1 NP_001399622.1 proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412682.1 NP_001399611.1 proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412683.1 NP_001399612.1 proto-oncogene tyrosine-protein kinase Src isoform 1
NM_009271.4 NP_033297.2 proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412687.1 NP_001399616.1 proto-oncogene tyrosine-protein kinase Src isoform 2
NM_001412686.1 NP_001399615.1 proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412684.1 NP_001399613.1 proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412685.1 NP_001399614.1 proto-oncogene tyrosine-protein kinase Src isoform 1
NM_001412688.1 NP_001399617.1 proto-oncogene tyrosine-protein kinase Src isoform 2
基因本体论
  • 分子功能
  • 生物过程
  • 细胞组分
分子功能 GO 注释 逻辑证据 参考文献 来源
enables connexin binding IPI
IPI: 通过物理相互作用推断
14699011 MGI
enables ephrin receptor binding IPI
IPI: 通过物理相互作用推断
12925710 MGI
enables kinase activity IMP
IMP: 通过突变表型推断
12808090 MGI
enables protein binding IPI
IPI: 通过物理相互作用推断
7518772 MGI
enables protein domain specific binding IPI
IPI: 通过物理相互作用推断
8438166 MGI
enables protein kinase activity IDA
IDA: 通过直接分析推断
11274221 MGI
enables protein kinase activity IMP
IMP: 通过突变表型推断
23100514 MGI
enables protein tyrosine kinase activity EXP
EXP: 通过实验结果推断
22759635 MGI
enables protein tyrosine kinase activity IDA
IDA: 通过直接分析推断
8910389 MGI
enables protein tyrosine kinase activity IMP
IMP: 通过突变表型推断
12091389 MGI
enables scaffold protein binding IPI
IPI: 通过物理相互作用推断
12091389 MGI
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in angiotensin-activated signaling pathway IGI
IGI: 通过遗传相互作用推断
25017399 MGI
acts upstream of or within bone resorption IMP
IMP: 通过突变表型推断
19448635 MGI
involved in bone resorption IMP
IMP: 通过突变表型推断
14739300 MGI
acts upstream of or within branching involved in mammary gland duct morphogenesis IMP
IMP: 通过突变表型推断
16007215 MGI
acts upstream of or within cell migration IMP
IMP: 通过突变表型推断
15292044 MGI
acts upstream of or within cellular response to fluid shear stress IMP
IMP: 通过突变表型推断
24841674 MGI
acts upstream of or within cellular response to hydrogen peroxide IMP
IMP: 通过突变表型推断
23651497 MGI
involved in cellular response to peptide hormone stimulus IGI
IGI: 通过遗传相互作用推断
25017399 MGI
acts upstream of or within cellular response to platelet-derived growth factor stimulus IDA
IDA: 通过直接分析推断
17623777 MGI
acts upstream of or within cellular response to reactive oxygen species IDA
IDA: 通过直接分析推断
24190966 MGI
acts upstream of or within cellular response to transforming growth factor beta stimulus IGI
IGI: 通过遗传相互作用推断
21829547 MGI
acts upstream of or within forebrain development IGI
IGI: 通过遗传相互作用推断
16162939 MGI
involved in interleukin-6-mediated signaling pathway IDA
IDA: 通过直接分析推断
25731159 MGI
involved in intestinal epithelial cell development IDA
IDA: 通过直接分析推断
25731159 MGI
acts upstream of or within intracellular signal transduction IGI
IGI: 通过遗传相互作用推断
23526378 MGI
acts upstream of or within odontogenesis IMP
IMP: 通过突变表型推断
23174213 MGI
acts upstream of or within oogenesis IMP
IMP: 通过突变表型推断
16007215 MGI
acts upstream of or within osteoclast development IGI
IGI: 通过遗传相互作用推断
23526378 MGI
acts upstream of or within peptidyl-tyrosine phosphorylation IDA
IDA: 通过直接分析推断
12526740 MGI
involved in peptidyl-tyrosine phosphorylation IMP
IMP: 通过突变表型推断
27505886 MGI
involved in phosphorylation IMP
IMP: 通过突变表型推断
12091389 MGI
involved in positive regulation of ERK1 and ERK2 cascade IMP
IMP: 通过突变表型推断
17045821 MGI
involved in positive regulation of Notch signaling pathway IDA
IDA: 通过直接分析推断
25731159 MGI
acts upstream of or within positive regulation of canonical Wnt signaling pathway IGI
IGI: 通过遗传相互作用推断
19920076 MGI
involved in positive regulation of glycolytic process IDA
IDA: 通过直接分析推断
35263589 MGI
acts upstream of or within positive regulation of peptidyl-tyrosine phosphorylation IGI
IGI: 通过遗传相互作用推断
17344476 MGI
acts upstream of or within positive regulation of platelet-derived growth factor receptor-beta signaling pathway IMP
IMP: 通过突变表型推断
23651497 MGI
acts upstream of or within positive regulation of podosome assembly IDA
IDA: 通过直接分析推断
21525037 MGI
acts upstream of or within positive regulation of podosome assembly IGI
IGI: 通过遗传相互作用推断
21525037 MGI
acts upstream of or within positive regulation of protein localization to nucleus IGI
IGI: 通过遗传相互作用推断
17344476 MGI
acts upstream of or within positive regulation of protein processing IGI
IGI: 通过遗传相互作用推断
17344476 MGI
involved in protein destabilization IMP
IMP: 通过突变表型推断
25259869 MGI
acts upstream of or within protein phosphorylation IDA
IDA: 通过直接分析推断
11274221 MGI
acts upstream of or within regulation of cell projection assembly IGI
IGI: 通过遗传相互作用推断
11864995 MGI
involved in regulation of heart rate by cardiac conduction IGI
IGI: 通过遗传相互作用推断
25017399 MGI
acts upstream of or within regulation of intracellular estrogen receptor signaling pathway IMP
IMP: 通过突变表型推断
16007215 MGI
acts upstream of or within regulation of protein binding IDA
IDA: 通过直接分析推断
22027834 MGI
acts upstream of or within substrate adhesion-dependent cell spreading IDA
IDA: 通过直接分析推断
11864995 MGI
acts upstream of or within uterus development IMP
IMP: 通过突变表型推断
16007215 MGI
细胞组分 GO 注释 逻辑证据 参考文献 来源
located in actin filament IDA
IDA: 通过直接分析推断
17623777 MGI
located in caveola IDA
IDA: 通过直接分析推断
12091389 MGI
located in cytoplasm IDA
IDA: 通过直接分析推断
14699011 MGI
located in cytoskeleton IDA
IDA: 通过直接分析推断
12615910 MGI
located in focal adhesion IMP
IMP: 通过突变表型推断
22801373 MGI
located in membrane IMP
IMP: 通过突变表型推断
22801373 MGI
located in mitochondrial inner membrane IDA
IDA: 通过直接分析推断
12615910 MGI
located in mitochondrion IDA
IDA: 通过直接分析推断
12615910 MGI
located in nucleus IDA
IDA: 通过直接分析推断
12615910 MGI
located in perinuclear region of cytoplasm IDA
IDA: 通过直接分析推断
17623777 MGI
located in plasma membrane IDA
IDA: 通过直接分析推断
12615910 MGI
located in podosome IDA
IDA: 通过直接分析推断
17893324 MGI
located in ruffle membrane IDA
IDA: 通过直接分析推断
17623777 MGI
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

Src 蛋白结构

SH3_Src

SH3_Src: cd12008 (86 - 141)

SH2_Src_Src

SH2_Src_Src: cd10365 (145 - 245)

PTKc_Src

PTKc_Src: cd05071 (258 - 534)

  • 0
  • 100
  • 200
  • 300
  • 400
  • 500
  • 535 a.a.
蛋白主名 其他名称

proto-oncogene tyrosine-protein kinase Src

neuronal proto-oncogene tyrosine-protein kinase Src

p60-Src

proto-oncogene c-Src

重组 Src 蛋白

目录号 产品名 蛋白编号 纯度
HY-P73423 Src Protein, Mouse (sf9, His-GST) P05480-2 (M1-L535) ≥95%

相关产品

Approval
生物活性分子 (10)
目录号 产品名 作用方式
纯度 是否罕见病
HY-10181 Dasatinib Inhibitor 99.85% 是
HY-12047 Ponatinib Inhibitor 99.67% 是
HY-10158 Bosutinib Inhibitor 99.96% 是
HY-10209 Masitinib Inhibitor 99.98% 是
HY-10181A Dasatinib hydrochloride Inhibitor 99.67% 是
HY-108766 Ponatinib hydrochloride Inhibitor 99.55% 是
HY-10209A Masitinib mesylate Inhibitor 99.51% 是
HY-10340B Tirbanibulin Mesylate Inhibitor 99.94% 否
HY-10181B Dasatinib monohydrate Inhibitor 98.48% 是
HY-10158A Bosutinib hydrate Inhibitor 99.97% 是
Clinical Phase
生物活性分子 (18)
目录号 产品名 作用方式
纯度 Phase
HY-10234 Saracatinib Inhibitor 99.92% Phase 3
HY-10340 Tirbanibulin Inhibitor 99.45% Phase 3
HY-13314 Tesevatinib Inhibitor 99.41% Phase 3
HY-10340A Tirbanibulin dihydrochloride Inhibitor 99.59% Phase 3
HY-121705 Propionyl-L-carnitine Activator ≥95.0% Phase 3
HY-13024 Rebastinib Inhibitor 99.91% Phase 2
HY-50868 Bafetinib Inhibitor 99.77% Phase 2
HY-15323 PRT062607 Hydrochloride Inhibitor 98.07% Phase 2
HY-32718 Pelitinib Inhibitor 99.13% Phase 2
HY-59047 Tolimidone Activator 99.98% Phase 2
HY-111787 Elzovantinib Inhibitor 99.93% Phase 2
HY-10987A ENMD-2076 Inhibitor 99.99% Phase 2
HY-10186 TG 100801 Inhibitor 98.61% Phase 2
HY-10987 ENMD-2076 Tartrate Inhibitor 99.42% Phase 2
HY-10187 TG 100801 Hydrochloride Inhibitor / Phase 2
HY-15749 XL228 Inhibitor 99.64% Phase 1
HY-112809 GSK2646264 Inhibitor 98.39% Phase 1
HY-112314 AZD0424 Inhibitor / Phase 1
Pre-clinical Phase
生物活性分子 (176)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-13805 PP2 Inhibitor 98.34% 否
HY-12299 WH-4-023 Inhibitor 99.75% 否
HY-N0752 Scutellarein Inhibitor 99.25% 否
HY-B0789 SU6656 Inhibitor 99.01% 否
HY-12072 Lck Inhibitor Inhibitor 99.45% 否
HY-101053 Src Inhibitor 1 Inhibitor 99.93% 否
HY-112096 eCF506 Inhibitor 99.77% 否
HY-N0031 Plantamajoside 99.52% 否
HY-15764A A 419259 trihydrochloride Inhibitor 99.21% 否
HY-136848 SM1-71 Inhibitor 96.09% 否
HY-W062835 CGP77675 Inhibitor 99.00% 否
HY-13804 PP1 Inhibitor 99.00% 否
HY-135299 CH6953755 Inhibitor 99.45% 否
HY-N7264 7α-Hydroxycholesterol 99.99% 否
HY-130254 CSK-IN-1 Inhibitor 98.61% 否
HY-11011 A-770041 Inhibitor 99.95% 否
HY-13942 1-NM-PP1 Inhibitor 99.17% 否
HY-10032 PF 477736 Inhibitor 99.21% 否
HY-15764 A 419259 Inhibitor 99.75% 否
HY-13941 1-Naphthyl PP1 Inhibitor 99.08% 否
HY-112852 TL02-59 Inhibitor 99.84% 否
HY-N0202 Atractylenolide II Inhibitor 99.94% 否
HY-10395 PD173955 Inhibitor 99.12% 否
HY-18303 AMG-47a Inhibitor 99.34% 否
HY-139147 iHCK-37 Inhibitor 99.52% 否
HY-132166 M4205 Inhibitor 99.47% 否
HY-10372 PP121 Inhibitor 98.67% 否
HY-78263 MNS Inhibitor 99.55% 否
HY-155657 BT424 Inhibitor 98.81% 否
HY-P3279 EPQpYEEIPIYL Activator 99.62% 否
HY-108318 RK-24466 Inhibitor 98.53% 否
HY-112182 UM-164 Inhibitor 99.15% 否
HY-18622 PP58 Inhibitor 99.75% 否
HY-122113 PD173952 Inhibitor 99.44% 否
HY-13561 AZM475271 Inhibitor 99.85% 否
HY-101795 Larixyl acetate Inhibitor 99.46% 否
HY-101963 AD80 Inhibitor 99.88% 否
HY-136605 DGY-06-116 Inhibitor 99.54% 否
HY-100434 PD-161570 Inhibitor 99.82% 否
HY-118144 PD166326 Inhibitor 99.99% 否
HY-108488 KB SRC 4 Inhibitor 99.66% 否
HY-163144 DAS-5-oCRBN Degrader 98.75% 否
HY-10644 Lck inhibitor 2 Inhibitor 99.73% 否
HY-146127A Grb2 SH2 domain inhibitor 1 TFA Inhibitor 99.71% 否
HY-159480 AD1058 Inhibitor 98.11% 否
HY-107024 Osteogenic Growth Peptide (10-14) Inhibitor 99.77% 否
HY-N0701 (-)-Asarinin Inhibitor 99.90% 否
HY-120213 YH-306 Inhibitor 98.34% 否
HY-N4127 3'-Demethylnobiletin 99.98% 否
HY-108485 Damnacanthal Inhibitor ≥98.0% 否
HY-15805 KIN-8194 Inhibitor 98.01% 否
HY-103274 PD180970 Inhibitor 99.27% 否
HY-120595 JNJ-49095397 Inhibitor 99.85% 否
HY-P1377A Caffeic acid-pYEEIE TFA 98.47% 否
HY-127002 Squarunkin A Inhibitor 99.34% 否
HY-13941B 1-Naphthyl PP1 hydrochloride Inhibitor 99.83% 否
HY-10181S Dasatinib-d8 Inhibitor 98.17% 否
HY-153556 GW297361 Inhibitor 98.13% 否
HY-10185 TG 100572 Hydrochloride Inhibitor 98.96% 否
HY-N4201 β-Hydroxyisovalerylshikonin Inhibitor 99.83% 否
HY-18623 VI 16832 Ligand 98.82% 否
HY-155582 BLK degrader 1 Degrader 98.92% 否
HY-108016 Peruvoside Inhibitor 99.32% 否
HY-112345 PD-089828 Inhibitor 98.07% 否
HY-132150A HPK1-IN-2 dihydrochloride Inhibitor 98.69% 否
HY-15324 PRT062607 acetate Inhibitor 99.83% 否
HY-15814 HG-7-85-01 Inhibitor 99.94% 否
HY-123506 Fenlean Inhibitor 99.56% 否
HY-W744699 Larixol Inhibitor 95.52% 否
HY-N6596 7-Hydroxy-4H-chromen-4-one Inhibitor 99.94% 否
HY-125028 Hck-IN-1 Inhibitor 98.53% 否
HY-18237 KX1-004 Inhibitor 99.75% 否
HY-136849 TL13-68 Inhibitor 98.88% 否
HY-10234A Saracatinib difumarate Inhibitor 99.24% 是
HY-13342AS Apatinib-d8 free base 92.56% 否
HY-112291 SB 220025 Inhibitor 99.90% 否
HY-111187 KX2-361 Inhibitor 99.55% 否
HY-W013857 Lavendustin C Inhibitor 98.32% 否
HY-18507 AD57 Inhibitor 98.08% 否
HY-15764G A 419259 (GMP) Inhibitor / 否
HY-147314 HIV-IN-6 98.35% 否
HY-116028 15-deoxy-Δ12,14-Prostaglandin D2 Activator ≥98.0% 否
HY-156914 IGF-1R/SRC-IN-1 Inhibitor 99.86% 否
HY-163469 SRC-3-IN-2 Inhibitor / 否
HY-123298 Chrysotoxine Inhibitor / 否
HY-12047S Ponatinib-d8 Inhibitor 99.91% 否
HY-138202 Lck-IN-1 Inhibitor 99.6% 否
HY-10158S Bosutinib-d8 Inhibitor ≥99.0% 否
HY-155587 Hydroxy-PP Inhibitor 99.66% 否
HY-118105 RK-20448 Inhibitor 99.38% 否
HY-16906 T338C Src-IN-2 Inhibitor / 否
HY-16905 T338C Src-IN-1 Inhibitor / 否
HY-10184 TG 100572 Inhibitor / 否
HY-N7160 2-Hydroxy-3-methylanthraquinone Inhibitor 99.60% 否
HY-P2547A Tyrosine Kinase Peptide 1 acetate / 否
HY-157998 mG2N001 / 否
HY-112852A TL02-59 dihydrochloride Inhibitor / 否
HY-P2547 Tyrosine Kinase Peptide 1 / 否
HY-149921 Antiangiogenic agent 3 Inhibitor / 否
HY-125387 TOP1210 / 否
HY-128397 CpCDPK1/TgCDPK1-IN-1 Inhibitor / 否
HY-P3773 p60c-src substrate II / 否
HY-P2372 P60v-src(137-157) Inhibitor / 否
HY-P1200 Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH Inhibitor / 否
HY-18507A AD57 hydrochloride Inhibitor / 否
HY-110367A LCB 03-0110 Inhibitor / 否
HY-P1111A Lyn peptide inhibitor TFA Inhibitor / 否
HY-P3743 p60c-src Substrate / 否
HY-170958 Scr-IN-1 Inhibitor / 否
HY-170971 Src Inhibitor 4 Inhibitor / 否
HY-W745090 Isomaltulose monohydrate Inhibitor / 否
HY-121828 TX-1123 Inhibitor / 否
HY-162291 Lck-IN-3 Inhibitor / 否
HY-168893 K882 Inhibitor / 否
HY-150026 Multi-kinase-IN-2 Inhibitor / 否
HY-P1200A Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH TFA Inhibitor / 否
HY-137918 TGF-βRI inhibitor 3 Inhibitor / 否
HY-P3771 p60c-src substrate II, phosphorylated / 否
HY-P1784 Secretin, canine / 否
HY-15268 PP487 Inhibitor / 否
HY-10363 AP 24149 Inhibitor / 否
HY-163468 SRC-3-IN-1 Inhibitor / 否
HY-136699 Excisanin A Inhibitor / 否
HY-13314A Tesevatinib tosylate Inhibitor / 否
HY-162879 FAK inhibitor 7 Inhibitor / 否
HY-157497 DA5-HTL Inhibitor / 否
HY-135216 Antiproliferative agent-54 Inhibitor / 否
HY-100824 PP2 Analog Inhibitor / 否
HY-P10372 pFYN peptide / 否
HY-P1111 Lyn peptide inhibitor Inhibitor / 否
HY-P0200 RR-SRC / 否
HY-10181G Dasatinib (GMP) Inhibitor / 否
HY-121849 KL-1156 Inhibitor / 否
HY-115723 Antiallergic agent-1 Inhibitor / 否
HY-139890 DC-Srci-6649 Inhibitor / 否
HY-157290 HL403 Inhibitor / 否
HY-112393 TX-1918 Inhibitor / 否
HY-163278 Lck-IN-2 Inhibitor / 否
HY-112335 Lck Inhibitor III Inhibitor / 否
HY-P10665 pYEEI Inhibitor / 否
HY-172096 cSRC/BCR-ABL-IN-1 Inhibitor / 否
HY-P10527 CSK substrate / 否
HY-161687 Cisplatin/Dasatinib prodrug-1 Inhibitor / 否
HY-102073 TG53 Inhibitor / 否
HY-W062835A CGP77675 hydrate Inhibitor / 否
HY-110367 LCB 03-0110 dihydrochloride Inhibitor / 否
HY-101447 SI-2 Inhibitor / 否
HY-168901 Hck-IN-2 Inhibitor / 否
HY-12847 CCT241161 Inhibitor / 否
HY-P2413 Ac-PPPHPHARIK-NH2 Inhibitor / 否
HY-162676 SJ45566 Degrader / 否
HY-112096S eCF506-d5 Inhibitor / 否
HY-168187 Src Inhibitor 3 Inhibitor / 否
HY-146014 Multi-kinase-IN-1 Inhibitor / 否
HY-127002A Squarunkin A hydrochloride Inhibitor / 否
HY-101268 CHMFL-ABL-053 Inhibitor / 否
HY-162413 (R)-LW-Srci-8 Inhibitor / 否
HY-169670 Protein kinase inhibitor 13 Inhibitor / 否
HY-160930 TOP1288 Inhibitor / 否
HY-171218 CGP062464 Inhibitor / 否
HY-122585 proMMP-9 inhibitor-3c Inhibitor / 否
HY-164527 Si306 Inhibitor / 否
HY-120622 BMS-243117 Inhibitor / 否
HY-171217 TG-100435 Inhibitor / 否
HY-W844558 Protein kinase inhibitor 11 Inhibitor / 否
HY-125064 AP22408 Inhibitor / 否
HY-10234S Saracatinib-d3 Inhibitor / 否
HY-10181S1 Dasatinib-d4 Inhibitor / 否
HY-112291A SB 220025 (tri(hydrochloride)) Inhibitor / 否
HY-N12166 2,3,4,6,8-Pentahydroxy-1-methylxanthone Inhibitor / 否
HY-136622 A-420983 Inhibitor / 否
HY-164530 SKLB646 Inhibitor / 否
HY-W994722 ISO24 Ligand / 否
HY-W700620 Hydroxymethyl dasatinib Inhibitor 99.92% 否
HY-10158AR Bosutinib (hydrate) (Standard) Inhibitor / 否
HY-P1377 Caffeic acid-pYEEIE / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens Src NCBI NCBI:6714
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z